Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Unresectable primary hepatic adenosquamous carcinoma successfully treated with systemic and transcatheter hepatic arterial injection chemotherapies followed by conversion surgery: a case report and literature review

Fig. 3

Changes in tumor markers during chemotherapy, conversion surgery, and postoperative adjuvant chemotherapy. Tumor markers gradually decrease along with systemic and transcatheter hepatic arterial injection chemotherapies. After 9 courses of treatment, the patient undergoes conversion surgery. Postoperative adjuvant chemotherapy was administered with no recurrence of the tumor. CDDP, cisplatin; CT, computed tomography; PR, partial remission; S-1, Tegafur/Gimeracil/Oteracil; TAI, transcatheter hepatic arterial injection; SCC, squamous cell carcinoma antigen; CYFRA, cytokeratin 19 fragment

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us